TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 92 filers reported holding TANGO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $990 | +429.4% | 87,882 | +56.2% | 0.00% | – |
| Q2 2023 | $187 | -20.4% | 56,264 | -5.5% | 0.00% | – |
| Q1 2023 | $235 | -60.8% | 59,529 | -27.9% | 0.00% | – |
| Q4 2022 | $599 | -99.9% | 82,522 | -31.1% | 0.00% | – |
| Q3 2022 | $433,000 | -31.2% | 119,715 | -13.8% | 0.00% | – |
| Q2 2022 | $629,000 | -32.5% | 138,836 | +13.0% | 0.00% | -100.0% |
| Q1 2022 | $932,000 | – | 122,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $87,719,000 | 57.68% |
| TCG Crossover Management, LLC | 1,172,250 | $5,310,000 | 2.26% |
| Boxer Capital, LLC | 6,871,642 | $31,129,000 | 1.97% |
| Cormorant Asset Management, LP | 4,507,843 | $20,421,000 | 1.54% |
| Casdin Capital, LLC | 3,500,000 | $15,855,000 | 1.34% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $8,706,000 | 1.02% |
| Samsara BioCapital, LLC | 630,000 | $2,854,000 | 0.76% |
| Southpoint Capital Advisors LP | 4,500,000 | $20,385,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 708,385 | $3,209,000 | 0.37% |
| EcoR1 Capital, LLC | 2,302,065 | $10,428,000 | 0.36% |